首页 > 最新文献

Abdominal Radiology最新文献

英文 中文
Revolutionizing radiology education: exploring innovative teaching methods 革新放射学教育:探索创新的教学方法。
IF 2.2 3区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-06-02 DOI: 10.1007/s00261-025-05010-x
Izzet Altun, Ozerk Turan, Omer Awan

The field of radiology education is undergoing a paradigm shift due to technological advancements and the increasing complexity of medical imaging. Traditional didactic teaching methods are progressively being supplemented or replaced by innovative pedagogical approaches that enhance engagement, competency, and clinical preparedness. This review examines the evolution of radiology education, highlighting novel teaching methodologies such as simulation-based training, artificial intelligence assisted learning, virtual and augmented reality, flipped classrooms, and case-based learning. Furthermore, this manuscript discusses the challenges of integrating these methodologies into radiology curricula and explores potential future directions in radiology education.

由于技术进步和医学成像的日益复杂,放射学教育领域正在经历范式转变。传统的说教式教学方法正逐渐被创新的教学方法所补充或取代,这些方法可以提高参与度、能力和临床准备。本文回顾了放射学教育的发展,重点介绍了新的教学方法,如基于模拟的培训、人工智能辅助学习、虚拟和增强现实、翻转教室和基于案例的学习。此外,本文讨论了将这些方法整合到放射学课程中的挑战,并探讨了放射学教育的潜在未来方向。
{"title":"Revolutionizing radiology education: exploring innovative teaching methods","authors":"Izzet Altun,&nbsp;Ozerk Turan,&nbsp;Omer Awan","doi":"10.1007/s00261-025-05010-x","DOIUrl":"10.1007/s00261-025-05010-x","url":null,"abstract":"<div><p>The field of radiology education is undergoing a paradigm shift due to technological advancements and the increasing complexity of medical imaging. Traditional didactic teaching methods are progressively being supplemented or replaced by innovative pedagogical approaches that enhance engagement, competency, and clinical preparedness. This review examines the evolution of radiology education, highlighting novel teaching methodologies such as simulation-based training, artificial intelligence assisted learning, virtual and augmented reality, flipped classrooms, and case-based learning. Furthermore, this manuscript discusses the challenges of integrating these methodologies into radiology curricula and explores potential future directions in radiology education.</p></div>","PeriodicalId":7126,"journal":{"name":"Abdominal Radiology","volume":"50 12","pages":"6225 - 6234"},"PeriodicalIF":2.2,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00261-025-05010-x.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144201302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of gallbladder motility in intrahepatic cholestasis of pregnancy: a prospective observational study 胆囊运动对妊娠肝内胆汁淤积的影响:一项前瞻性观察研究。
IF 2.2 3区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-06-02 DOI: 10.1007/s00261-025-04986-w
Ashish Verma, Ishan Kumar, Anisha Kumari, UMA PANDEY, Pramod Kumar Singh

Background

Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder that occurs during pregnancy, typically in the third trimester, and is associated with adverse fetal outcomes. Despite being well-recognized, the exact pathogenesis of ICP remains incompletely understood, with impaired hepatobiliary function hypothesized to play a significant role in its development.

Purpose

The study aims to evaluate the relationship between altered gallbladder motility and hepatobiliary dysfunction in pregnancies complicated by ICP.

Materials and methods

This was a prospective hospital-based study involving 90 participants: 30 non-pregnant controls and 60 pregnant women (30 with intrahepatic cholestasis of pregnancy (ICP), and 30 pregnant controls). The cholestasis group was further subdivided into an icteric group (elevated serum bilirubin levels) and an anicteric group (abnormal liver function tests but normal bilirubin levels). Gallbladder volume (GBV) was initially measured after an overnight fast (12–14 h). Following a standardized meal (75 g of bread and butter or 100 g of groundnut), GBV and ejection fraction were re-measured at multiple postprandial time points (15, 30, 45, 60, 75, and 90 min).

Results

The study enrolled 60 pregnant women in their third trimester (gestational weeks 28–40) and 30 non-pregnant controls. Among the pregnant women, 30 were diagnosed with ICP, which was further divided into an icteric group (n = 6) and an anicteric group (n = 24). The ICP group demonstrated consistently higher GB volumes and lower ejection fraction (EF) compared to non-pregnant and pregnant controls, with statistically significant differences across all time intervals. Within the ICP patients, the icteric group consistently exhibited higher GB volumes and lower EF values compared to anicteric group. Receiver operating characteristic (ROC) curve analysis revealed that the best post-prandial 15-min GB ejection fraction cutoff for predicting ICP was 53% and postprandial 15-min GB volume cutoff for predicting ICP was 9.5 ml,

Conclusion

Impaired gallbladder motility, characterized by increased GB volume and decreased EF, is a key feature of obstetric cholestasis. Gallbladder ultrasound measurements, particularly postprandial GB volume and EF, can serve as useful diagnostic tools for distinguishing between cholestasis of pregnancy and healthy pregnancies, with high sensitivity and specificity for identifying ICP in late pregnancy.

背景:妊娠肝内胆汁淤积症(ICP)是一种发生在妊娠期间的肝脏疾病,通常发生在妊娠晚期,并与不良胎儿结局相关。尽管已经得到了广泛的认识,但ICP的确切发病机制仍不完全清楚,肝胆功能受损可能在其发展中起重要作用。目的:探讨妊娠合并ICP患者胆囊运动改变与肝胆功能障碍的关系。材料和方法:这是一项基于医院的前瞻性研究,涉及90名参与者:30名非孕妇对照组和60名孕妇(30名患有妊娠肝内胆汁淤积症(ICP), 30名孕妇对照组)。胆汁淤积组进一步细分为黄疸组(血清胆红素水平升高)和无黄疸组(肝功能检查异常但胆红素水平正常)。在禁食过夜(12-14小时)后首次测量胆囊体积(GBV)。标准化膳食(75克面包和黄油或100克花生)后,在餐后多个时间点(15、30、45、60、75和90分钟)重新测量GBV和射血分数。结果:该研究招募了60名妊娠晚期(孕28-40周)的孕妇和30名未怀孕的对照组。其中30例孕妇诊断为ICP,进一步分为黄疸组(n = 6)和无黄疸组(n = 24)。与未怀孕组和怀孕组相比,ICP组始终表现出更高的GB容量和更低的射血分数(EF),在所有时间间隔中都有统计学上的显著差异。在ICP患者中,与无黄疸组相比,黄疸组始终表现出更高的GB体积和更低的EF值。受试者工作特征(ROC)曲线分析显示,餐后15分钟GB射血分数预测ICP的最佳临界值为53%,餐后15分钟GB容量预测ICP的最佳临界值为9.5 ml。结论:胆囊运动功能受损,以GB容量增加和EF降低为特征,是产科胆汁淤积的关键特征。胆囊超声测量,特别是餐后GB容积和EF,可作为区分妊娠期胆汁淤积和健康妊娠的有用诊断工具,对妊娠晚期ICP的识别具有高灵敏度和特异性。
{"title":"The impact of gallbladder motility in intrahepatic cholestasis of pregnancy: a prospective observational study","authors":"Ashish Verma,&nbsp;Ishan Kumar,&nbsp;Anisha Kumari,&nbsp;UMA PANDEY,&nbsp;Pramod Kumar Singh","doi":"10.1007/s00261-025-04986-w","DOIUrl":"10.1007/s00261-025-04986-w","url":null,"abstract":"<div><h3>Background</h3><p>Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder that occurs during pregnancy, typically in the third trimester, and is associated with adverse fetal outcomes. Despite being well-recognized, the exact pathogenesis of ICP remains incompletely understood, with impaired hepatobiliary function hypothesized to play a significant role in its development.</p><h3>Purpose</h3><p>The study aims to evaluate the relationship between altered gallbladder motility and hepatobiliary dysfunction in pregnancies complicated by ICP.</p><h3>Materials and methods</h3><p>This was a prospective hospital-based study involving 90 participants: 30 non-pregnant controls and 60 pregnant women (30 with intrahepatic cholestasis of pregnancy (ICP), and 30 pregnant controls). The cholestasis group was further subdivided into an icteric group (elevated serum bilirubin levels) and an anicteric group (abnormal liver function tests but normal bilirubin levels). Gallbladder volume (GBV) was initially measured after an overnight fast (12–14 h). Following a standardized meal (75 g of bread and butter or 100 g of groundnut), GBV and ejection fraction were re-measured at multiple postprandial time points (15, 30, 45, 60, 75, and 90 min).</p><h3>Results</h3><p>The study enrolled 60 pregnant women in their third trimester (gestational weeks 28–40) and 30 non-pregnant controls. Among the pregnant women, 30 were diagnosed with ICP, which was further divided into an icteric group (n = 6) and an anicteric group (n = 24). The ICP group demonstrated consistently higher GB volumes and lower ejection fraction (EF) compared to non-pregnant and pregnant controls, with statistically significant differences across all time intervals. Within the ICP patients, the icteric group consistently exhibited higher GB volumes and lower EF values compared to anicteric group. Receiver operating characteristic (ROC) curve analysis revealed that the best post-prandial 15-min GB ejection fraction cutoff for predicting ICP was 53% and postprandial 15-min GB volume cutoff for predicting ICP was 9.5 ml,</p><h3>Conclusion</h3><p>Impaired gallbladder motility, characterized by increased GB volume and decreased EF, is a key feature of obstetric cholestasis. Gallbladder ultrasound measurements, particularly postprandial GB volume and EF, can serve as useful diagnostic tools for distinguishing between cholestasis of pregnancy and healthy pregnancies, with high sensitivity and specificity for identifying ICP in late pregnancy.</p></div>","PeriodicalId":7126,"journal":{"name":"Abdominal Radiology","volume":"50 12","pages":"5810 - 5819"},"PeriodicalIF":2.2,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144201303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemical exchange saturation transfer magnetic resonance imaging of the kidney: applications and challenges 化学交换饱和转移肾磁共振成像:应用和挑战。
IF 2.2 3区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-05-31 DOI: 10.1007/s00261-025-04980-2
Lu Liu, Songlin Guo, Zhaoyu Xing, Xingtian Yu, Wenxia Mi, Jiule Ding, Jie Chen, Wei Xing, Liang Pan

The kidney plays a crucial role in regulating the acid-base balance of the body. The development of kidney diseases is often accompanied by changes in the renal PH, protein, glucose, urea, and other metabolites. Chemical exchange saturation transfer (CEST) imaging is a new magnetic resonance imaging (MRI) technique based on the chemical exchange between solute and water protons. The potential of CEST imaging in renal metabolic imaging stems from its ability to provide image contrast based on specific molecular compositions at relevant millimolar physiological concentrations. In this article, we briefly introduce the fundamental principles of CEST imaging and its applications in various renal disorders, including acute kidney injury, chronic kidney disease, renal tumors, and renal allograft rejection. Finally, we discuss the challenges and prospects of CEST imaging in the field of kidney diseases.

AbstractSection Graphical abstract
肾脏在调节人体酸碱平衡方面起着至关重要的作用。肾脏疾病的发展往往伴随着肾脏PH值、蛋白质、葡萄糖、尿素等代谢物的变化。化学交换饱和转移成像(CEST)是一种基于溶质与水质子之间化学交换的新型磁共振成像技术。CEST成像在肾脏代谢成像中的潜力源于其基于相关毫摩尔生理浓度的特定分子组成提供图像对比的能力。本文简要介绍CEST成像的基本原理及其在各种肾脏疾病中的应用,包括急性肾损伤、慢性肾脏疾病、肾肿瘤和肾移植排斥反应。最后,我们讨论了CEST成像在肾脏疾病领域的挑战和前景。摘要部分图形摘要
{"title":"Chemical exchange saturation transfer magnetic resonance imaging of the kidney: applications and challenges","authors":"Lu Liu,&nbsp;Songlin Guo,&nbsp;Zhaoyu Xing,&nbsp;Xingtian Yu,&nbsp;Wenxia Mi,&nbsp;Jiule Ding,&nbsp;Jie Chen,&nbsp;Wei Xing,&nbsp;Liang Pan","doi":"10.1007/s00261-025-04980-2","DOIUrl":"10.1007/s00261-025-04980-2","url":null,"abstract":"<div>\u0000 \u0000 <p>The kidney plays a crucial role in regulating the acid-base balance of the body. The development of kidney diseases is often accompanied by changes in the renal PH, protein, glucose, urea, and other metabolites. Chemical exchange saturation transfer (CEST) imaging is a new magnetic resonance imaging (MRI) technique based on the chemical exchange between solute and water protons. The potential of CEST imaging in renal metabolic imaging stems from its ability to provide image contrast based on specific molecular compositions at relevant millimolar physiological concentrations. In this article, we briefly introduce the fundamental principles of CEST imaging and its applications in various renal disorders, including acute kidney injury, chronic kidney disease, renal tumors, and renal allograft rejection. Finally, we discuss the challenges and prospects of CEST imaging in the field of kidney diseases.</p>\u0000 <span>AbstractSection</span>\u0000 Graphical abstract\u0000 <div><figure><div><div><picture><source><img></source></picture></div></div></figure></div>\u0000 \u0000 </div>","PeriodicalId":7126,"journal":{"name":"Abdominal Radiology","volume":"50 12","pages":"5934 - 5947"},"PeriodicalIF":2.2,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00261-025-04980-2.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144192649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of transient severe motion artifacts on gadoxetic acid–enhanced MRI: frequency and risk factors gadoxetic酸增强MRI上短暂剧烈运动伪影的研究:频率和危险因素。
IF 2.2 3区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-05-31 DOI: 10.1007/s00261-025-05040-5
Yuttapol Hirun, Wittanee Na Chiang Mai, Suwalee Pojchamarnwiputh, Nakarin Inmutto

Purpose

To evaluate the frequency and independent risk factors associated with transient severe motion artifact (TSM) during the arterial phase of gadoxetic acid–enhanced liver MRI in a Southeast Asian population.

Materials and methods

This retrospective study included 836 consecutive studies who underwent gadoxetic acid–enhanced MRI between October 2022 and October 2024 at a tertiary academic hospital. Two abdominal radiologists reviewed arterial phase images and graded motion artifacts using a validated 5-point scale; grades 4 and 5 were classified as TSM. Clinical and laboratory data were extracted from the electronic medical record. Univariable and multivariable logistic regression analyses were performed to identify predictors of TSM. Subgroup analyses were conducted based on age and body mass index (BMI).

Results

TSM artifacts were observed in 43 of 836 studies (5.14%). In multivariable analysis, older age (> 65 years) (adjusted OR 4.59; 95% CI 1.268–16.710; p = 0.021) and lower serum albumin (adjusted OR 0.33; 95% CI 0.143–0.761; p = 0.009) were independent predictors of TSM. Subgroup analyses demonstrated higher TSM incidence in patients aged ≥ 65 years (7.07% vs. 3.41%; p = 0.019) and in those with BMI > 30 kg/m2 (11.11% vs. 4.73%; p = 0.052). Other variables, including sex, comorbidities, liver disease etiology, and fluid overload, were not significantly associated with TSM.

Conclusion

TSM during gadoxetic acid–enhanced liver MRI occurs in approximately 5% of patients and is independently associated with older age and lower serum albumin. Awareness of these risk factors can guide protocol optimization and personalized imaging strategies to improve arterial phase image quality.

目的:评估东南亚人群加多西酸增强肝脏MRI动脉期短暂性剧烈运动伪影(TSM)的频率和独立危险因素。材料和方法:本回顾性研究纳入了2022年10月至2024年10月在某三级学术医院接受加多辛酸增强MRI的836例连续研究。两名腹部放射科医生回顾了动脉期图像,并使用有效的5分制对运动伪影进行了分级;4、5级为TSM。从电子病历中提取临床和实验室数据。采用单变量和多变量logistic回归分析确定TSM的预测因子。根据年龄和身体质量指数(BMI)进行亚组分析。结果:836项研究中有43项(5.14%)出现TSM伪影。在多变量分析中,年龄较大(60 ~ 65岁)(调整OR 4.59;95% ci 1.268-16.710;p = 0.021)和较低的血清白蛋白(调整OR 0.33;95% ci 0.143-0.761;p = 0.009)是TSM的独立预测因子。亚组分析显示≥65岁患者TSM发病率较高(7.07% vs. 3.41%;p = 0.019), BMI为bbb30 kg/m2者(11.11% vs. 4.73%;p = 0.052)。其他变量,包括性别、合并症、肝脏疾病病因和体液超载,与TSM无显著相关性。结论:约5%的患者在加多etic酸增强肝脏MRI期间出现TSM,并与年龄和血清白蛋白水平降低独立相关。了解这些危险因素可以指导方案优化和个性化成像策略,以提高动脉期图像质量。
{"title":"Investigation of transient severe motion artifacts on gadoxetic acid–enhanced MRI: frequency and risk factors","authors":"Yuttapol Hirun,&nbsp;Wittanee Na Chiang Mai,&nbsp;Suwalee Pojchamarnwiputh,&nbsp;Nakarin Inmutto","doi":"10.1007/s00261-025-05040-5","DOIUrl":"10.1007/s00261-025-05040-5","url":null,"abstract":"<div><h3>Purpose</h3><p>To evaluate the frequency and independent risk factors associated with transient severe motion artifact (TSM) during the arterial phase of gadoxetic acid–enhanced liver MRI in a Southeast Asian population.</p><h3>Materials and methods</h3><p>This retrospective study included 836 consecutive studies who underwent gadoxetic acid–enhanced MRI between October 2022 and October 2024 at a tertiary academic hospital. Two abdominal radiologists reviewed arterial phase images and graded motion artifacts using a validated 5-point scale; grades 4 and 5 were classified as TSM. Clinical and laboratory data were extracted from the electronic medical record. Univariable and multivariable logistic regression analyses were performed to identify predictors of TSM. Subgroup analyses were conducted based on age and body mass index (BMI).</p><h3>Results</h3><p>TSM artifacts were observed in 43 of 836 studies (5.14%). In multivariable analysis, older age (&gt; 65 years) (adjusted OR 4.59; 95% CI 1.268–16.710; <i>p</i> = 0.021) and lower serum albumin (adjusted OR 0.33; 95% CI 0.143–0.761; <i>p</i> = 0.009) were independent predictors of TSM. Subgroup analyses demonstrated higher TSM incidence in patients aged ≥ 65 years (7.07% vs. 3.41%; <i>p</i> = 0.019) and in those with BMI &gt; 30 kg/m<sup>2</sup> (11.11% vs. 4.73%; <i>p</i> = 0.052). Other variables, including sex, comorbidities, liver disease etiology, and fluid overload, were not significantly associated with TSM.</p><h3>Conclusion</h3><p>TSM during gadoxetic acid–enhanced liver MRI occurs in approximately 5% of patients and is independently associated with older age and lower serum albumin. Awareness of these risk factors can guide protocol optimization and personalized imaging strategies to improve arterial phase image quality.</p></div>","PeriodicalId":7126,"journal":{"name":"Abdominal Radiology","volume":"50 12","pages":"6214 - 6224"},"PeriodicalIF":2.2,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00261-025-05040-5.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144192651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and validation of a nomogram model based on ultrasound and contrast-enhanced ultrasound features for differentiating mass-forming pancreatitis and pancreatic ductal adenocarcinoma 基于超声和增强超声特征鉴别肿块形成型胰腺炎和胰腺导管腺癌的nomogram模型的建立和验证。
IF 2.2 3区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-05-31 DOI: 10.1007/s00261-025-05035-2
Hua Liang, Yang Gui, Xueqi Chen, Tianjiao Chen, Jing Zhang, Li Tan, Wanying Jia, Menghua Dai, Weibin Wang, Junchao Guo, Qiang Xu, Ke Lv, Yuxing Jiang

Purpose

To explore the value of ultrasound (US) and contrast-enhanced ultrasound (CEUS) in differentiating mass-forming Pancreatitis (MFP) and pancreatic ductal adenocarcinoma (PDAC).

Methods

This retrospective study analyzed clinical and imaging data from 281 patients who underwent pancreatic CEUS between January 2018 and December 2023. Patients were randomly divided into training (n = 196) and validation (n = 85) sets. Logistic regression analyses were conducted to identify independent predictive imaging features for differentiating PDAC from MFP in the training set. Based on the identified predictors, two nomogram models were constructed: the US model and the US + CEUS model. The diagnostic performance of both models was assessed via the area under the receiver operating characteristic curve (AUC), calibration plots, Hosmer-Lemeshow test, and decision-curve analysis (DCA).

Results

Multivariate logistic regression analysis based on these factors identified taller-than-wide shape (P = 0.002, OR = 0.12), calcification (P = 0.003, OR = 13.76), and washout pattern (P = 0.002, OR = 0.13) as independent predictive factors for distinguishing PDAC from MFP. Compared to the US model, the US + CEUS model demonstrated better performance with AUC values 0.930 (95% CI: 0.895–0.965) in the training set and 0.914 (95% CI: 0.853–0.976) in the validation set. Calibration curve plots and the Hosmer-Lemeshow test (P > 0.05) confirmed that the model has good calibration, and DAC showed significant clinical benefit.

Conclusion

The nomogram model constructed using taller-than-wide shape, calcification, and washout pattern demonstrated excellent discriminative ability, accuracy, and clinical utility in differentiating PDAC from MFP.

目的:探讨超声(US)和增强超声(CEUS)对肿块形成性胰腺炎(MFP)和胰腺导管腺癌(PDAC)的鉴别价值。方法:本回顾性研究分析了2018年1月至2023年12月期间接受胰腺超声造影的281例患者的临床和影像学资料。患者随机分为训练组(n = 196)和验证组(n = 85)。进行了逻辑回归分析,以确定独立的预测成像特征,以区分训练集中的PDAC和MFP。在此基础上,构建了US模型和US + CEUS模型。两种模型的诊断性能通过受试者工作特征曲线下面积(AUC)、校准图、Hosmer-Lemeshow检验和决策曲线分析(DCA)进行评估。结果:基于这些因素的多因素logistic回归分析发现,高宽形状(P = 0.002, OR = 0.12)、钙化(P = 0.003, OR = 13.76)和洗脱模式(P = 0.002, OR = 0.13)是区分PDAC和MFP的独立预测因素。与US模型相比,US + CEUS模型在训练集中的AUC值为0.930 (95% CI: 0.895-0.965),在验证集中的AUC值为0.914 (95% CI: 0.853-0.976),表现出更好的性能。校正曲线图和Hosmer-Lemeshow检验(P > 0.05)证实模型具有良好的校正性,DAC具有显著的临床效益。结论:采用高宽形状、钙化和冲洗模式构建的nomogram模型在区分PDAC和MFP方面具有出色的鉴别能力、准确性和临床实用性。
{"title":"Development and validation of a nomogram model based on ultrasound and contrast-enhanced ultrasound features for differentiating mass-forming pancreatitis and pancreatic ductal adenocarcinoma","authors":"Hua Liang,&nbsp;Yang Gui,&nbsp;Xueqi Chen,&nbsp;Tianjiao Chen,&nbsp;Jing Zhang,&nbsp;Li Tan,&nbsp;Wanying Jia,&nbsp;Menghua Dai,&nbsp;Weibin Wang,&nbsp;Junchao Guo,&nbsp;Qiang Xu,&nbsp;Ke Lv,&nbsp;Yuxing Jiang","doi":"10.1007/s00261-025-05035-2","DOIUrl":"10.1007/s00261-025-05035-2","url":null,"abstract":"<div><h3>Purpose</h3><p>To explore the value of ultrasound (US) and contrast-enhanced ultrasound (CEUS) in differentiating mass-forming Pancreatitis (MFP) and pancreatic ductal adenocarcinoma (PDAC).</p><h3>Methods</h3><p>This retrospective study analyzed clinical and imaging data from 281 patients who underwent pancreatic CEUS between January 2018 and December 2023. Patients were randomly divided into training (<i>n</i> = 196) and validation (<i>n</i> = 85) sets. Logistic regression analyses were conducted to identify independent predictive imaging features for differentiating PDAC from MFP in the training set. Based on the identified predictors, two nomogram models were constructed: the US model and the US + CEUS model. The diagnostic performance of both models was assessed via the area under the receiver operating characteristic curve (AUC), calibration plots, <i>Hosmer-Lemeshow</i> test, and decision-curve analysis (DCA).</p><h3>Results</h3><p>Multivariate logistic regression analysis based on these factors identified taller-than-wide shape (<i>P</i> = 0.002, <i>OR</i> = 0.12), calcification (<i>P</i> = 0.003, <i>OR</i> = 13.76), and washout pattern (<i>P</i> = 0.002, <i>OR</i> = 0.13) as independent predictive factors for distinguishing PDAC from MFP. Compared to the US model, the US + CEUS model demonstrated better performance with AUC values 0.930 (95% <i>CI</i>: 0.895–0.965) in the training set and 0.914 (95% <i>CI</i>: 0.853–0.976) in the validation set. Calibration curve plots and the <i>Hosmer-Lemeshow</i> test (<i>P</i> &gt; 0.05) confirmed that the model has good calibration, and DAC showed significant clinical benefit.</p><h3>Conclusion</h3><p>The nomogram model constructed using taller-than-wide shape, calcification, and washout pattern demonstrated excellent discriminative ability, accuracy, and clinical utility in differentiating PDAC from MFP.</p></div>","PeriodicalId":7126,"journal":{"name":"Abdominal Radiology","volume":"50 12","pages":"6148 - 6160"},"PeriodicalIF":2.2,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00261-025-05035-2.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144192650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between spleen volume and diameter for assessment of response to treatment on CT in patients with hematologic malignancies enrolled in clinical trials 脾体积与脾直径的关系评价临床试验中恶性血液病患者对CT治疗的反应。
IF 2.2 3区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-05-31 DOI: 10.1007/s00261-025-05030-7
Kyle A. Hasenstab, Jie Lu, Lambert T. Leong, Emily Bossard, Evye Pylarinou-Sinclair, Karthika Devi, Guilherme M. Cunha

Purpose

Investigate spleen diameter (d) and volume (v) relationship in patients with hematologic malignancies (HM) by determining volumetric thresholds that best correlate to established diameter thresholds for assessing response to treatment. Exploratorily, interrogate the impact of volumetric measurements in response categories and as a predictor of response.

Methods

Secondary analysis of prospectively collected clinical trial data of 382 patients with HM. Spleen diameters were computed following Lugano criteria and volumes using deep learning segmentation. d and v relationship was estimated using power regression model, volumetric thresholds ((:{v}_{threshold})) for treatment response estimated; threshold search to determine percentual change ((:{v}_{%}),) and minimum volumetric increase ((:{v}_{increase})) that maximize agreement with Lugano criteria performed. Spleen diameter and volume predictive performance for clinical response investigated using random forest model.

Results

(:v=2.24times:{d}^{2.14}) describes the relationship between spleen diameter and volume. (:{v}_{threshold}) for splenomegaly was 546 cm³. (:{v}_{threshold}), (:{v}_{%}), and (:{v}_{increase}) for assessing response resulting in highest agreement with Lugano criteria were 570 cm3, 73%, and 170 cm3, respectively. Predictive performance for response between diameter and volume were not significantly different (P=0.78).

Conclusion

This study provides empirical spleen volume threshold and percentual changes that best correlate with diameter thresholds, i.e., Lugano criteria, for assessment of response to treatment in patients with HM. In our dataset use of spleen volumetric thresholds versus diameter thresholds resulted in similar response assessment categories and did not signal differences in predictive values for response.

目的:研究恶性血液病(HM)患者脾脏直径(d)和体积(v)的关系,通过确定与已建立的直径阈值最相关的体积阈值来评估治疗反应。探索性地询问体积测量在响应类别中的影响,并作为响应的预测因子。方法:对前瞻性收集的382例HM患者临床试验资料进行二次分析。脾脏直径按照Lugano标准计算,体积使用深度学习分割。采用幂回归模型估计d和v的关系,体积阈值(公式见文)用于估计治疗反应;阈值搜索,以确定百分比变化([公式:见文本]和最小体积增加([公式:见文本]),最大限度地符合卢加诺标准执行。采用随机森林模型研究脾脏直径和体积对临床反应的预测性能。结果:[公式:见文]描述脾脏直径与体积的关系。【公式:见文】脾肿大为546 cm³。[公式:见文]、[公式:见文]和[公式:见文]评估反应,结果与卢加诺标准的最高一致性分别为570 cm3、73%和170 cm3。直径和体积对反应的预测性能无显著差异(P=0.78)。结论:本研究提供了与直径阈值相关性最好的脾脏体积阈值和百分比变化,即Lugano标准,用于评估HM患者的治疗反应。在我们的数据集中,脾脏体积阈值与直径阈值的使用导致了相似的反应评估类别,并且没有表明反应预测值的差异。
{"title":"Relationship between spleen volume and diameter for assessment of response to treatment on CT in patients with hematologic malignancies enrolled in clinical trials","authors":"Kyle A. Hasenstab,&nbsp;Jie Lu,&nbsp;Lambert T. Leong,&nbsp;Emily Bossard,&nbsp;Evye Pylarinou-Sinclair,&nbsp;Karthika Devi,&nbsp;Guilherme M. Cunha","doi":"10.1007/s00261-025-05030-7","DOIUrl":"10.1007/s00261-025-05030-7","url":null,"abstract":"<div><h3>Purpose</h3><p>Investigate spleen diameter (<i>d</i>) and volume (<i>v</i>) relationship in patients with hematologic malignancies (HM) by determining volumetric thresholds that best correlate to established diameter thresholds for assessing response to treatment. Exploratorily, interrogate the impact of volumetric measurements in response categories and as a predictor of response.</p><h3>Methods</h3><p>Secondary analysis of prospectively collected clinical trial data of 382 patients with HM. Spleen diameters were computed following Lugano criteria and volumes using deep learning segmentation. <i>d</i> and <i>v</i> relationship was estimated using power regression model, volumetric thresholds (<span>(:{v}_{threshold})</span>) for treatment response estimated; threshold search to determine percentual change (<span>(:{v}_{%}),)</span> and minimum volumetric increase (<span>(:{v}_{increase})</span>) that maximize agreement with Lugano criteria performed. Spleen diameter and volume predictive performance for clinical response investigated using random forest model.</p><h3>Results</h3><p><span>(:v=2.24times:{d}^{2.14})</span> describes the relationship between spleen diameter and volume. <span>(:{v}_{threshold})</span> for splenomegaly was 546 cm³. <span>(:{v}_{threshold})</span>, <span>(:{v}_{%})</span>, and <span>(:{v}_{increase})</span> for assessing response resulting in highest agreement with Lugano criteria were 570 cm<sup>3</sup>, 73%, and 170 cm<sup>3</sup>, respectively. Predictive performance for response between diameter and volume were not significantly different (<i>P</i>=0.78).</p><h3>Conclusion</h3><p>This study provides empirical spleen volume threshold and percentual changes that best correlate with diameter thresholds, i.e., Lugano criteria, for assessment of response to treatment in patients with HM. In our dataset use of spleen volumetric thresholds versus diameter thresholds resulted in similar response assessment categories and did not signal differences in predictive values for response.</p></div>","PeriodicalId":7126,"journal":{"name":"Abdominal Radiology","volume":"50 12","pages":"5799 - 5809"},"PeriodicalIF":2.2,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144192652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress in multimodal radiomics of rectal cancer tumors and peritumoral regions in MRI 直肠癌肿瘤及肿瘤周围MRI多模态放射组学研究进展。
IF 2.2 3区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-05-31 DOI: 10.1007/s00261-025-04965-1
Tingting Gong, Ying Gao, He Li, Jianqiu Wang, Zili Li, Qinghai Yuan

Rectal cancer (RC) is one of the most common malignant tumors of the digestive system and has an alarmingly high incidence and mortality rate globally. Compared to conventional imaging examinations, radiomics can extract quantitative features that reflect tumor heterogeneity and mine data from medical images. In this review, we discuss the potential value of multimodal MRI-based radiomics in the diagnosis and treatment of RC, with a special emphasis on the role of peritumoral tissue characteristics in clinical decision-making. Existing studies have shown that a radiomics model integrating intratumoral and peritumoral characteristics has good application prospects in RC staging evaluation, efficacy prediction, metastasis monitoring, recurrence early warning, and prognosis judgment. At the same time, this paper also objectively analyzes the existing methodological limitations in this field, including insufficient data standardization, inadequate model validation, limited sample size and poor reproducibility of results. By combining existing evidence, this review aimed to enhance the attention of clinicians and radiologists on the characteristics of peritumoral tissues and promote the translational application of radiomics technology in the individualized treatment of RC.

Graphical abstract

直肠癌(RC)是最常见的消化系统恶性肿瘤之一,在全球范围内具有惊人的高发病率和死亡率。与传统影像学检查相比,放射组学可以提取反映肿瘤异质性的定量特征,并从医学图像中挖掘数据。在这篇综述中,我们讨论了基于多模态mri的放射组学在RC诊断和治疗中的潜在价值,特别强调了肿瘤周围组织特征在临床决策中的作用。已有研究表明,结合瘤内和瘤周特征的放射组学模型在RC分期评价、疗效预测、转移监测、复发预警、预后判断等方面具有良好的应用前景。同时,本文也客观分析了该领域现有的方法学局限性,包括数据标准化程度不高、模型验证不充分、样本量有限、结果可重复性差等。本文结合现有证据,旨在提高临床医生和放射科医生对肿瘤周围组织特征的重视,促进放射组学技术在RC个体化治疗中的转化应用。
{"title":"Research progress in multimodal radiomics of rectal cancer tumors and peritumoral regions in MRI","authors":"Tingting Gong,&nbsp;Ying Gao,&nbsp;He Li,&nbsp;Jianqiu Wang,&nbsp;Zili Li,&nbsp;Qinghai Yuan","doi":"10.1007/s00261-025-04965-1","DOIUrl":"10.1007/s00261-025-04965-1","url":null,"abstract":"<div><p>Rectal cancer (RC) is one of the most common malignant tumors of the digestive system and has an alarmingly high incidence and mortality rate globally. Compared to conventional imaging examinations, radiomics can extract quantitative features that reflect tumor heterogeneity and mine data from medical images. In this review, we discuss the potential value of multimodal MRI-based radiomics in the diagnosis and treatment of RC, with a special emphasis on the role of peritumoral tissue characteristics in clinical decision-making. Existing studies have shown that a radiomics model integrating intratumoral and peritumoral characteristics has good application prospects in RC staging evaluation, efficacy prediction, metastasis monitoring, recurrence early warning, and prognosis judgment. At the same time, this paper also objectively analyzes the existing methodological limitations in this field, including insufficient data standardization, inadequate model validation, limited sample size and poor reproducibility of results. By combining existing evidence, this review aimed to enhance the attention of clinicians and radiologists on the characteristics of peritumoral tissues and promote the translational application of radiomics technology in the individualized treatment of RC.</p><h3>Graphical abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":7126,"journal":{"name":"Abdominal Radiology","volume":"50 12","pages":"5677 - 5689"},"PeriodicalIF":2.2,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00261-025-04965-1.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144192653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using AI to triage patients without clinically significant prostate cancer using biparametric MRI and PSA 利用人工智能通过双参数MRI和PSA对无临床意义的前列腺癌患者进行分类。
IF 2.2 3区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-05-30 DOI: 10.1007/s00261-025-05019-2
Emerson P. Grabke, Carolina A. M. Heming, Amit Hadari, Antonio Finelli, Sangeet Ghai, Katherine Lajkosz, Babak Taati, Masoom A. Haider

Objectives

To train and evaluate the performance of a machine learning triaging tool that identifies MRI negative for clinically significant prostate cancer and to compare this against non-MRI models.

Methods

2895 MRIs were collected from two sources (1630 internal, 1265 public) in this retrospective study. Risk models compared were: Prostate Cancer Prevention Trial Risk Calculator 2.0, Prostate Biopsy Collaborative Group Calculator, PSA density, U-Net segmentation, and U-Net combined with clinical parameters. The reference standard was histopathology or negative follow-up. Performance metrics were calculated by simulating a triaging workflow compared to radiologist interpreting all exams on a test set of 465 patients. Sensitivity and specificity differences were assessed using the McNemar test. Differences in PPV and NPV were assessed using the Leisenring, Alonzo and Pepe generalized score statistic. Equivalence test p-values were adjusted within each measure using Benjamini–Hochberg correction.

Results

Triaging using U-Net with clinical parameters reduced radiologist workload by 12.5% with sensitivity decrease from 93 to 90% (p = 0.023) and specificity increase from 39 to 47% (p < 0.001). This simulated workload reduction was greater than triaging with risk calculators (3.2% and 1.3%, p < 0.001), and comparable to PSA density (8.4%, p = 0.071) and U-Net alone (11.6%, p = 0.762). Both U-Net triaging strategies increased PPV (+ 2.8% p = 0.005 clinical, + 2.2% p = 0.020 nonclinical), unlike non-U-Net strategies (p > 0.05). NPV remained equivalent for all scenarios (p > 0.05). Clinically-informed U-Net triaging correctly ruled out 20 (13.4%) radiologist false positives (12 PI-RADS = 3, 8 PI-RADS = 4). Of the eight (3.6%) false negatives, two were misclassified by the radiologist. No misclassified case was interpreted as PI-RADS 5.

Conclusions

Prostate MRI triaging using machine learning could reduce radiologist workload by 12.5% with a 3% sensitivity decrease and 8% specificity increase, outperforming triaging using non-imaging-based risk models. Further prospective validation is required.

目的:训练和评估机器学习分类工具的性能,该工具可识别具有临床意义的MRI阴性前列腺癌,并将其与非MRI模型进行比较。方法:回顾性研究从两个来源收集2895个mri(1630个内部,1265个公众)。比较的风险模型有:前列腺癌预防试验风险计算器2.0、前列腺活检协同组计算器、PSA密度、U-Net分割、U-Net结合临床参数。参照标准为组织病理学或阴性随访。通过模拟分诊工作流程来计算性能指标,并与放射科医生解释465名患者的所有检查结果进行比较。使用McNemar试验评估敏感性和特异性差异。采用Leisenring、Alonzo和Pepe广义评分统计来评估PPV和NPV的差异。使用Benjamini-Hochberg校正对每个测量中的等价检验p值进行调整。结果:使用带有临床参数的U-Net进行分诊,使放射科医生的工作量减少了12.5%,敏感性从93%下降到90% (p = 0.023),特异性从39%上升到47% (p = 0.05)。NPV在所有情景下保持相等(p < 0.05)。临床知情的U-Net分诊正确排除了20例(13.4%)放射科假阳性(12例PI-RADS = 3,8例PI-RADS = 4)。在8例(3.6%)假阴性中,2例被放射科医生错误分类。没有误分类病例被解释为PI-RADS 5。结论:使用机器学习的前列腺MRI分诊可以减少放射科医生12.5%的工作量,敏感性降低3%,特异性提高8%,优于使用非基于成像的风险模型的分诊。需要进一步的前瞻性验证。
{"title":"Using AI to triage patients without clinically significant prostate cancer using biparametric MRI and PSA","authors":"Emerson P. Grabke,&nbsp;Carolina A. M. Heming,&nbsp;Amit Hadari,&nbsp;Antonio Finelli,&nbsp;Sangeet Ghai,&nbsp;Katherine Lajkosz,&nbsp;Babak Taati,&nbsp;Masoom A. Haider","doi":"10.1007/s00261-025-05019-2","DOIUrl":"10.1007/s00261-025-05019-2","url":null,"abstract":"<div><h3>Objectives</h3><p>To train and evaluate the performance of a machine learning triaging tool that identifies MRI negative for clinically significant prostate cancer and to compare this against non-MRI models.</p><h3>Methods</h3><p>2895 MRIs were collected from two sources (1630 internal, 1265 public) in this retrospective study. Risk models compared were: Prostate Cancer Prevention Trial Risk Calculator 2.0, Prostate Biopsy Collaborative Group Calculator, PSA density, U-Net segmentation, and U-Net combined with clinical parameters. The reference standard was histopathology or negative follow-up. Performance metrics were calculated by simulating a triaging workflow compared to radiologist interpreting all exams on a test set of 465 patients. Sensitivity and specificity differences were assessed using the McNemar test. Differences in PPV and NPV were assessed using the Leisenring, Alonzo and Pepe generalized score statistic. Equivalence test p-values were adjusted within each measure using Benjamini–Hochberg correction.</p><h3>Results</h3><p>Triaging using U-Net with clinical parameters reduced radiologist workload by 12.5% with sensitivity decrease from 93 to 90% (p = 0.023) and specificity increase from 39 to 47% (p &lt; 0.001). This simulated workload reduction was greater than triaging with risk calculators (3.2% and 1.3%, p &lt; 0.001), and comparable to PSA density (8.4%, p = 0.071) and U-Net alone (11.6%, p = 0.762). Both U-Net triaging strategies increased PPV (+ 2.8% p = 0.005 clinical, + 2.2% p = 0.020 nonclinical), unlike non-U-Net strategies (p &gt; 0.05). NPV remained equivalent for all scenarios (p &gt; 0.05). Clinically-informed U-Net triaging correctly ruled out 20 (13.4%) radiologist false positives (12 PI-RADS = 3, 8 PI-RADS = 4). Of the eight (3.6%) false negatives, two were misclassified by the radiologist. No misclassified case was interpreted as PI-RADS 5.</p><h3>Conclusions</h3><p>Prostate MRI triaging using machine learning could reduce radiologist workload by 12.5% with a 3% sensitivity decrease and 8% specificity increase, outperforming triaging using non-imaging-based risk models. Further prospective validation is required.</p></div>","PeriodicalId":7126,"journal":{"name":"Abdominal Radiology","volume":"50 12","pages":"5924 - 5933"},"PeriodicalIF":2.2,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144188671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound image-based contrastive fusion non-invasive liver fibrosis staging algorithm 基于超声图像的对比融合无创肝纤维化分期算法。
IF 2.2 3区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-05-29 DOI: 10.1007/s00261-025-04991-z
Xinyi Dong, Qinxiang Tan, Shu Xu, Jie Zhang, Mingqiang Zhou

Objective

The diagnosis of liver fibrosis is usually based on histopathological examination of liver puncture specimens. Although liver puncture is accurate, it has invasive risks and high economic costs, which are difficult for some patients to accept. Therefore, this study uses deep learning technology to build a liver fibrosis diagnosis model to achieve non-invasive staging of liver fibrosis, avoid complications, and reduce costs.

Methods

This study uses ultrasound examination to obtain pure liver parenchyma image section data. With the consent of the patient, combined with the results of percutaneous liver puncture biopsy, the degree of liver fibrosis indicated by ultrasound examination data is judged. The concept of Fibrosis Contrast Layer (FCL) is creatively introduced in our experimental method, which can help our model more keenly capture the significant differences in the characteristics of liver fibrosis of various grades. Finally, through label fusion (LF), the characteristics of liver specimens of the same fibrosis stage are abstracted and fused to improve the accuracy and stability of the diagnostic model.

Results

Experimental evaluation demonstrated that our model achieved an accuracy of 85.6%, outperforming baseline models such as ResNet (81.9%), InceptionNet (80.9%), and VGG (80.8%). Even under a small-sample condition (30% data), the model maintained an accuracy of 84.8%, significantly outperforming traditional deep-learning models exhibiting sharp performance declines.

Conclusion

The training results show that in the whole sample data set and 30% small sample data set training environments, the FCLLF model’s test performance results are better than those of traditional deep learning models such as VGG, ResNet, and InceptionNet. The performance of the FCLLF model is more stable, especially in the small sample data set environment. Our proposed FCLLF model effectively improves the accuracy and stability of liver fibrosis staging using non-invasive ultrasound imaging.

目的:肝纤维化的诊断通常基于肝穿刺标本的组织病理学检查。肝穿刺虽然准确,但存在侵入性风险和较高的经济成本,一些患者难以接受。因此,本研究利用深度学习技术构建肝纤维化诊断模型,实现肝纤维化的无创分期,避免并发症,降低成本。方法:本研究采用超声检查获得纯肝实质图像切片资料。经患者同意,结合经皮肝穿刺活检结果,判断超声检查数据指示的肝纤维化程度。我们的实验方法创造性地引入了纤维化对比层(Fibrosis Contrast Layer, FCL)的概念,可以帮助我们的模型更敏锐地捕捉到不同级别肝纤维化特征的显著差异。最后,通过标签融合(label fusion, LF),对同一纤维化分期肝脏标本的特征进行提取和融合,提高诊断模型的准确性和稳定性。结果:实验评估表明,我们的模型达到了85.6%的准确率,优于ResNet(81.9%)、InceptionNet(80.9%)和VGG(80.8%)等基线模型。即使在小样本条件下(30%数据),该模型也保持了84.8%的准确率,显著优于表现急剧下降的传统深度学习模型。结论:训练结果表明,在全样本数据集和30%小样本数据集训练环境下,FCLLF模型的测试性能结果优于VGG、ResNet、InceptionNet等传统深度学习模型。FCLLF模型的性能更稳定,特别是在小样本数据集环境下。我们提出的FCLLF模型有效地提高了无创超声成像肝纤维化分期的准确性和稳定性。
{"title":"Ultrasound image-based contrastive fusion non-invasive liver fibrosis staging algorithm","authors":"Xinyi Dong,&nbsp;Qinxiang Tan,&nbsp;Shu Xu,&nbsp;Jie Zhang,&nbsp;Mingqiang Zhou","doi":"10.1007/s00261-025-04991-z","DOIUrl":"10.1007/s00261-025-04991-z","url":null,"abstract":"<div><h3>Objective</h3><p>The diagnosis of liver fibrosis is usually based on histopathological examination of liver puncture specimens. Although liver puncture is accurate, it has invasive risks and high economic costs, which are difficult for some patients to accept. Therefore, this study uses deep learning technology to build a liver fibrosis diagnosis model to achieve non-invasive staging of liver fibrosis, avoid complications, and reduce costs.</p><h3>Methods</h3><p>This study uses ultrasound examination to obtain pure liver parenchyma image section data. With the consent of the patient, combined with the results of percutaneous liver puncture biopsy, the degree of liver fibrosis indicated by ultrasound examination data is judged. The concept of Fibrosis Contrast Layer (FCL) is creatively introduced in our experimental method, which can help our model more keenly capture the significant differences in the characteristics of liver fibrosis of various grades. Finally, through label fusion (LF), the characteristics of liver specimens of the same fibrosis stage are abstracted and fused to improve the accuracy and stability of the diagnostic model.</p><h3>Results</h3><p>Experimental evaluation demonstrated that our model achieved an accuracy of 85.6%, outperforming baseline models such as ResNet (81.9%), InceptionNet (80.9%), and VGG (80.8%). Even under a small-sample condition (30% data), the model maintained an accuracy of 84.8%, significantly outperforming traditional deep-learning models exhibiting sharp performance declines.</p><h3>Conclusion</h3><p>The training results show that in the whole sample data set and 30% small sample data set training environments, the FCLLF model’s test performance results are better than those of traditional deep learning models such as VGG, ResNet, and InceptionNet. The performance of the FCLLF model is more stable, especially in the small sample data set environment. Our proposed FCLLF model effectively improves the accuracy and stability of liver fibrosis staging using non-invasive ultrasound imaging.</p></div>","PeriodicalId":7126,"journal":{"name":"Abdominal Radiology","volume":"50 12","pages":"6135 - 6147"},"PeriodicalIF":2.2,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00261-025-04991-z.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144183110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving prostate MRI quality and its diagnostic impact: a prospective quality improvement initiative 提高前列腺MRI质量及其诊断影响:一个前瞻性的质量改进倡议。
IF 2.2 3区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-05-29 DOI: 10.1007/s00261-025-05011-w
Emily Knott, Jennifer Bullen, Rachel Harris, Kevin McDermott, Andrei Purysko, Ryan Ward

Purpose

High-quality imaging is critical for accurate prostate cancer assessment using MRI. This study describes a quality improvement (QI) initiative for prostate MRI and evaluates the impact of image quality on diagnostic performance.

Methods

In this prospective study, 1328 patients underwent prostate MRI between March 2023 and March 2024. The QI initiative focused on patient preparation, protocol standardization, technologist education, and quality control. Image quality was prospectively scored using the Prostate Imaging Quality (PI-QUAL) system. Diagnostic performance was assessed by comparing the positive predictive value (PPV) of PI-RADS ≥ 3 lesions before and after the intervention and between exams with optimal (PI-QUAL ≥ 4) and suboptimal quality. Fisher’s exact test was used for comparisons. Clinically significant prostate cancer (csPCa) was defined as Gleason Grade Group ≥ 2.

Results

The proportion of PI-QUAL ≥ 4 exams increased from 67 to 84% after the intervention (p < 0.001). The PPV for any prostate cancer improved from 65 to 78% (p = 0.03), though the increase for csPCa (from 42 to 46%) was not statistically significant (p = 0.5). No significant difference in PPV was observed between optimal and suboptimal exams for any cancer (76% vs. 77%, p = 0.9) or csPCa (45% vs. 48%, p = 0.7).

Conclusion

The QI initiative significantly improved image quality and overall cancer detection rates. However, the association between image quality and csPCa detection was not statistically significant, possibly due to greater improvements in T2-weighted images vs. diffusion weighted images and high reader expertise.

目的:高质量的成像对MRI准确评估前列腺癌至关重要。本研究描述了前列腺MRI的质量改进(QI)倡议,并评估了图像质量对诊断性能的影响。方法:在这项前瞻性研究中,1328名患者在2023年3月至2024年3月期间接受了前列腺MRI检查。QI计划的重点是患者准备、方案标准化、技术人员教育和质量控制。使用前列腺成像质量(PI-QUAL)系统对图像质量进行前瞻性评分。通过比较干预前后和最佳(PI-QUAL≥4)和次优质量检查之间PI-RADS≥3个病变的阳性预测值(PPV)来评估诊断效果。费雪精确检验用于比较。临床显著性前列腺癌(csPCa)定义为Gleason分级≥2组。结果:干预后PI-QUAL≥4项检查的比例从67%增加到84% (p)。结论:QI倡议显著提高了图像质量和总体癌症检出率。然而,图像质量与csPCa检测之间的关联在统计上并不显著,这可能是由于t2加权图像比扩散加权图像有更大的改善,以及更高的阅读器专业知识。
{"title":"Improving prostate MRI quality and its diagnostic impact: a prospective quality improvement initiative","authors":"Emily Knott,&nbsp;Jennifer Bullen,&nbsp;Rachel Harris,&nbsp;Kevin McDermott,&nbsp;Andrei Purysko,&nbsp;Ryan Ward","doi":"10.1007/s00261-025-05011-w","DOIUrl":"10.1007/s00261-025-05011-w","url":null,"abstract":"<div><h3>Purpose</h3><p>High-quality imaging is critical for accurate prostate cancer assessment using MRI. This study describes a quality improvement (QI) initiative for prostate MRI and evaluates the impact of image quality on diagnostic performance.</p><h3>Methods</h3><p>In this prospective study, 1328 patients underwent prostate MRI between March 2023 and March 2024. The QI initiative focused on patient preparation, protocol standardization, technologist education, and quality control. Image quality was prospectively scored using the Prostate Imaging Quality (PI-QUAL) system. Diagnostic performance was assessed by comparing the positive predictive value (PPV) of PI-RADS ≥ 3 lesions before and after the intervention and between exams with optimal (PI-QUAL ≥ 4) and suboptimal quality. Fisher’s exact test was used for comparisons. Clinically significant prostate cancer (csPCa) was defined as Gleason Grade Group ≥ 2.</p><h3>Results</h3><p>The proportion of PI-QUAL ≥ 4 exams increased from 67 to 84% after the intervention (<i>p</i> &lt; 0.001). The PPV for any prostate cancer improved from 65 to 78% (<i>p</i> = 0.03), though the increase for csPCa (from 42 to 46%) was not statistically significant (<i>p</i> = 0.5). No significant difference in PPV was observed between optimal and suboptimal exams for any cancer (76% vs. 77%, <i>p</i> = 0.9) or csPCa (45% vs. 48%, <i>p</i> = 0.7).</p><h3>Conclusion</h3><p>The QI initiative significantly improved image quality and overall cancer detection rates. However, the association between image quality and csPCa detection was not statistically significant, possibly due to greater improvements in T2-weighted images vs. diffusion weighted images and high reader expertise.</p></div>","PeriodicalId":7126,"journal":{"name":"Abdominal Radiology","volume":"50 12","pages":"5915 - 5923"},"PeriodicalIF":2.2,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144176423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Abdominal Radiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1